On November 20, 2019 Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, reported that Derek Maetzold, president and chief executive officer, will present at the following upcoming investor conferences (Press release, Castle Biosciences, NOV 20, 2019, View Source [SID1234551523]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Jaffray 31st Annual Healthcare Conference, New York
Presentation on Wednesday, December 4, 2019, at 2:30 p.m. EST
Evercore ISI 2nd Annual HealthCONx Conference, Boston
Presentation on Thursday, December 5, 2019, at 12:30 p.m. EST
Live audio webcasts of the company’s presentations will be available by visiting Castle Biosciences’ website at View Source A replay of the webcast will be available for two weeks following the conclusion of the live broadcast.